SK12872003A3 - Nádorové signálne znaky rakovinového nádoru obličkovej bunky - Google Patents
Nádorové signálne znaky rakovinového nádoru obličkovej bunky Download PDFInfo
- Publication number
- SK12872003A3 SK12872003A3 SK1287-2003A SK12872003A SK12872003A3 SK 12872003 A3 SK12872003 A3 SK 12872003A3 SK 12872003 A SK12872003 A SK 12872003A SK 12872003 A3 SK12872003 A3 SK 12872003A3
- Authority
- SK
- Slovakia
- Prior art keywords
- antibody
- rcc
- tumor
- protein
- tumor marker
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4712—Muscle proteins, e.g. myosin, actin, protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Hospice & Palliative Care (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01108385 | 2001-04-03 | ||
PCT/EP2002/003503 WO2002082076A2 (en) | 2001-04-03 | 2002-03-28 | Renal cell carcinoma tumor markers |
Publications (1)
Publication Number | Publication Date |
---|---|
SK12872003A3 true SK12872003A3 (sk) | 2004-02-03 |
Family
ID=8177036
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK1287-2003A SK12872003A3 (sk) | 2001-04-03 | 2002-03-28 | Nádorové signálne znaky rakovinového nádoru obličkovej bunky |
Country Status (15)
Country | Link |
---|---|
US (1) | US20040096916A1 (ja) |
EP (1) | EP1373900A2 (ja) |
JP (1) | JP2004531713A (ja) |
KR (1) | KR20030086345A (ja) |
CN (1) | CN1630819A (ja) |
BR (1) | BR0208603A (ja) |
CA (1) | CA2442957A1 (ja) |
CZ (1) | CZ20032787A3 (ja) |
HU (1) | HUP0303749A3 (ja) |
MX (1) | MXPA03009018A (ja) |
PL (1) | PL363009A1 (ja) |
RU (1) | RU2003130645A (ja) |
SK (1) | SK12872003A3 (ja) |
WO (1) | WO2002082076A2 (ja) |
ZA (1) | ZA200308487B (ja) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7947496B2 (en) | 1999-10-08 | 2011-05-24 | Hoffmann-La Roche Inc. | Cytotoxicity mediation of cells evidencing surface expression of CD44 |
US7252821B2 (en) * | 1999-10-08 | 2007-08-07 | Arius Research Inc. | Cancerous disease modifying antibodies |
US8048416B2 (en) | 1999-10-08 | 2011-11-01 | Hoffmann-La Roche Inc. | Cytotoxicity mediation of cells evidencing surface expression of CD44 |
US8071072B2 (en) | 1999-10-08 | 2011-12-06 | Hoffmann-La Roche Inc. | Cytotoxicity mediation of cells evidencing surface expression of CD44 |
US20040001789A1 (en) * | 1999-10-08 | 2004-01-01 | Young David S. F. | Cytotoxicity mediation of cells evidencing surface expression of gp96 or precursors thereof |
US7670604B2 (en) | 2002-12-13 | 2010-03-02 | Aurelium Biopharma, Inc. | Vimentin directed diagnostics and therapeutics for multidrug resistant neoplastic disease |
WO2004055517A2 (en) * | 2002-12-13 | 2004-07-01 | Aurelium Biopharma Inc. | Nucleophosmin directed diagnostics and therapeutics for multidrug resistant neoplastic disease |
WO2004061458A2 (en) | 2003-01-03 | 2004-07-22 | Aurelium Biopharma Inc. | Hsc70 directed diagnostics and therapeutics for multidrug resistant neoplastic disease |
WO2004080819A2 (en) * | 2003-03-14 | 2004-09-23 | Aurelium Biopharma Inc. | Triosephosphate isomerase directed diagnostics and therapeutics for multidrug resistant neoplastic disease |
WO2004096855A2 (en) * | 2003-04-28 | 2004-11-11 | Wyeth | Methods utilising g-protein coupled receptor 54 |
GB2402212B (en) * | 2003-05-28 | 2007-04-11 | Univ Chang Gung | Detecting recurrence and high stage bladder carcinoma |
WO2005078124A2 (de) * | 2004-02-16 | 2005-08-25 | Proteosys Ag | Diagnostische marker für krebs |
CN1712542B (zh) * | 2004-06-25 | 2012-07-04 | 中国科学院上海生命科学研究院 | 肝细胞癌相关的蛋白质分子标记原癌蛋白18的筛选及其应用 |
US20080119367A1 (en) * | 2004-12-17 | 2008-05-22 | Mayo Foundation For Medical Education And Research | Prognosis of Renal Cell Carcinoma |
US20060148674A1 (en) * | 2004-12-31 | 2006-07-06 | Luduena Richard F | Therapeutic composition |
AU2006210794A1 (en) * | 2005-02-01 | 2006-08-10 | Government Of The U.S.A., As Represented By The Secretary, Department Of Health & Human Services | Biomarkers for tissue status |
EP1724586A3 (en) * | 2005-05-21 | 2007-07-04 | ProteoSys AG | Annexin for cancer risk assessment |
EP1724585A1 (en) * | 2005-05-21 | 2006-11-22 | ProteoSys AG | Annexin for cancer risk assessment |
JP2007033041A (ja) * | 2005-07-22 | 2007-02-08 | Sumitomo Chemical Co Ltd | 胎盤型グルタチオン−s−トランスフェラ−ゼ酵素を認識する抗体に対して陰性を示すラット肝臓腫瘍性病変又は前腫瘍性病変の検定方法 |
EP1757940A1 (en) | 2005-08-26 | 2007-02-28 | Cézanne S.A.S. | In vitro method for diagnosing and monitoring renal cell carcinoma (RCC) using MMP-7 as humoral biomarker for RCC |
EP2404998B1 (en) * | 2005-09-02 | 2015-11-11 | Kyoto University | Composition and method for diagnosing kidney cancer and for predicting prognosis for kidney cancer patient |
EP1955076A4 (en) * | 2005-11-29 | 2009-11-25 | Denator Ab | METHOD FOR DETERMINING THE QUALITY OF A BIOLOGICAL SAMPLE |
JP5211315B2 (ja) * | 2006-07-25 | 2013-06-12 | 国立大学法人愛媛大学 | 腫瘍マーカ、腫瘍診断キットおよび腫瘍マーカの測定方法 |
US20090280512A1 (en) | 2006-09-15 | 2009-11-12 | Taro Masuda | Tumor marker for renal cancer and method for determination of occurrence of renal cancer |
JP5566293B2 (ja) * | 2007-10-04 | 2014-08-06 | バイオノミックス リミテッド | 内皮細胞マーカーおよびその使用 |
DE102008011850A1 (de) * | 2008-02-29 | 2009-09-03 | Michael Grzendowski | Biomarker für die Diagnose von Hirntumor |
CN105403701B (zh) * | 2008-04-11 | 2017-04-12 | 中国医学科学院肿瘤医院 | 膜联蛋白a2的血清检测方法、检测试剂盒及其应用 |
US20120003225A1 (en) * | 2008-05-09 | 2012-01-05 | Duke University | Autoantibodies in the detection and treatment of cancer |
CN103328978B (zh) * | 2011-01-21 | 2016-01-20 | 巴斯利尔药物股份公司 | stathmin作为呋咱并苯并咪唑类药物应答的生物标记的用途 |
CN102288470A (zh) * | 2011-07-20 | 2011-12-21 | 中国热带农业科学院热带生物技术研究所 | 一种考马斯亮蓝g250染色方法及其专用染色液和应用 |
CN102375061B (zh) * | 2011-09-20 | 2014-07-30 | 国家人口计生委科学技术研究所 | 一种检测前列腺癌的elisa试剂盒 |
JP5872285B2 (ja) * | 2011-12-28 | 2016-03-01 | 株式会社島津製作所 | 腎がん血中マーカー |
WO2014038744A1 (ko) * | 2012-09-07 | 2014-03-13 | 제노마인 | 신장암 혈액 바이오마커의 검출 방법 및 키트 |
HUE046176T2 (hu) * | 2012-10-24 | 2020-02-28 | Inregen | Vesesejt-populációk és alkalmazásaik |
EP2735874A1 (en) * | 2012-11-21 | 2014-05-28 | Fundación Para La Investigación Biomédica Del Hospital Universitario Puerta De Hierro | Methods of diagnosing and therapeutic agents for use in the treatment of prostate cancer |
SE538211C2 (sv) * | 2013-04-05 | 2016-04-05 | Idl Biotech Ab | Metod för detektering av cytokeratin 8, 18 och/eller 19 och/eller lösliga fragment därav |
CN104330570B (zh) * | 2014-10-11 | 2016-03-16 | 中国科学院微生物研究所 | 人热休克蛋白gp96在制备筛查肝病的产品中的应用 |
EP3411711B1 (en) | 2016-02-04 | 2022-08-03 | Immune System Key Ltd. | Endoplasmic reticulum stress as a predictive tool in cancer therapy and a combination therapy for the treatment of cancer |
CN106526185B (zh) * | 2016-10-28 | 2018-03-30 | 拜尔康(天津)医药科技有限公司 | 用于检测去势抵抗性前列腺癌的elisa试剂盒及检测方法 |
BR112019010002A2 (pt) * | 2016-12-16 | 2019-08-20 | Merck Patent Gmbh | métodos para o uso de proteína de ligação galectina-3 detectada na urina para monitoramento da gravidade e progressão da nefrite lúpica |
CN113447656B (zh) * | 2021-07-01 | 2022-05-13 | 浙江大学 | 检测抗丝状肌动蛋白成帽蛋白β-IgG抗体的试剂盒 |
CN114099639B (zh) * | 2021-11-25 | 2024-03-01 | 徐州医科大学 | H1-pHSP65纳米疫苗及其制备方法和用途 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5972626A (en) * | 1997-07-30 | 1999-10-26 | University Of Massachusetts | Cancer detection by centrosome abnormality |
-
2002
- 2002-03-28 CN CNA028068661A patent/CN1630819A/zh active Pending
- 2002-03-28 PL PL02363009A patent/PL363009A1/xx unknown
- 2002-03-28 HU HU0303749A patent/HUP0303749A3/hu unknown
- 2002-03-28 CA CA002442957A patent/CA2442957A1/en not_active Abandoned
- 2002-03-28 US US10/473,601 patent/US20040096916A1/en not_active Abandoned
- 2002-03-28 JP JP2002579795A patent/JP2004531713A/ja not_active Withdrawn
- 2002-03-28 SK SK1287-2003A patent/SK12872003A3/sk unknown
- 2002-03-28 WO PCT/EP2002/003503 patent/WO2002082076A2/en not_active Application Discontinuation
- 2002-03-28 MX MXPA03009018A patent/MXPA03009018A/es unknown
- 2002-03-28 EP EP02759781A patent/EP1373900A2/en not_active Withdrawn
- 2002-03-28 CZ CZ20032787A patent/CZ20032787A3/cs unknown
- 2002-03-28 RU RU2003130645/15A patent/RU2003130645A/ru not_active Application Discontinuation
- 2002-03-28 BR BR0208603-4A patent/BR0208603A/pt not_active Application Discontinuation
- 2002-03-28 KR KR10-2003-7013015A patent/KR20030086345A/ko not_active Application Discontinuation
-
2003
- 2003-10-30 ZA ZA200308487A patent/ZA200308487B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA200308487B (en) | 2005-01-31 |
PL363009A1 (en) | 2004-11-15 |
US20040096916A1 (en) | 2004-05-20 |
MXPA03009018A (es) | 2004-02-12 |
HUP0303749A2 (hu) | 2004-03-01 |
JP2004531713A (ja) | 2004-10-14 |
BR0208603A (pt) | 2004-03-02 |
HUP0303749A3 (en) | 2005-09-28 |
WO2002082076A2 (en) | 2002-10-17 |
CN1630819A (zh) | 2005-06-22 |
KR20030086345A (ko) | 2003-11-07 |
RU2003130645A (ru) | 2005-04-10 |
WO2002082076A3 (en) | 2003-09-04 |
CA2442957A1 (en) | 2002-10-17 |
CZ20032787A3 (en) | 2004-03-17 |
EP1373900A2 (en) | 2004-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SK12872003A3 (sk) | Nádorové signálne znaky rakovinového nádoru obličkovej bunky | |
US20210145700A1 (en) | Genetic products differentially expressed in tumors and the use thereof | |
AU2010202440B2 (en) | Genetic products differentially expressed in tumors and the use thereof | |
CA2879185C (en) | Method for detecting cancer | |
JP6886816B2 (ja) | 免疫系調節薬 | |
CA2879304A1 (en) | Method for detecting cancer | |
US20190194345A1 (en) | Anti-sas1b antibodies, associated methods of use, and compositions and methods for detecting and treating cancer | |
US20090221004A1 (en) | Caspase-cleavage anti-keratin antibodies for detection of apoptosis | |
KR101458483B1 (ko) | 신장암 진단 조성물 및 키트 | |
US20170313770A1 (en) | Reagents for detecting or diagnosing cancer cells having high invasive capacity | |
EP3656794A1 (en) | Composition and methods for detecting cancer | |
US20100330554A1 (en) | Diagnostic kit for solid cancer and medicament for solid cancer therapy | |
JPWO2009044561A1 (ja) | 抗proNT/NMNモノクローナル抗体 | |
US20080305499A1 (en) | Anti-Synoviolin Antibody | |
JPH0816679B2 (ja) | 体液および組織におけるrasタンパクの検出、定量および分類 | |
WO2022080305A1 (ja) | 抗ptdss2抗体 | |
JP6729917B2 (ja) | EphA2 N末端フラグメント抗体 | |
JPWO2003084991A1 (ja) | アトピー性皮膚炎誘引蛋白質 | |
AU2002308206A1 (en) | Renal cell carcinoma tumor markers | |
AU2016203425B2 (en) | Genetic products differentially expressed in tumors and the use thereof | |
AU2013260709B2 (en) | Genetic products differentially expressed in tumors and the use thereof | |
JP4395004B2 (ja) | 胚細胞腫瘍の検出方法 | |
EP2527361B1 (en) | Biomarkers for in vitro prognosis and diagnosis of graft and transplant rejection | |
AU2011256897B2 (en) | Genetic products differentially expressed in tumors and the use thereof | |
KR20120060049A (ko) | 비만 바이오마커 검출용 조성물 및 키트 |